Dermira Reports Third Quarter 2019 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Dermira (DERM) Tops Q3 EPS by 24c
November 5, 2019 5:15 PM ESTDermira (NASDAQ: DERM) reported Q3 EPS of ($1.06), $0.24 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $11.22 million.
The third quarter was marked by notable progress on key commercial, clinical and regulatory initiatives as we... More
